Views & Analysis Pandemic boost to decentralised trials is here to stay Due to the pandemic, decentralised trial solutions made the shift from an emerging trend to a crucial element of drug development.
Partner Content Partner Content Making the most of your remaining communications budget pharmaphorum connect's Mark Walmsley describes seven projects to maximise remaining communications budgets.
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends